In a recent paper, Horder and colleagues (Horder et al., 2010, J Psychopharmacol 25: 1277–1288) have suggested that the mainproblem in the Kirsch analysis is methodological. We argue that the results are similar irrespective of the method used. In our opinion the data suggest that placebo and drug effects are non-additive: antidepressants act independently of depression severity, while the placebo effect is present only in milder cases. While the response in the placebo group is due to unstable ‘noise’ and ‘artefacts’, the medication effect is reliable, valid and stable
The placebo response plays a major role in psychiatry, particularly in depression. A new network met...
International audienceBACKGROUND: Antidepressants are often considered to be mere placebos despite t...
Introduction: During the last decade, a number of meta-analyses questioned the clinically relevant e...
In a recent paper, Horder and colleagues (Horder et al., 2010, J Psychopharmacol 25: 1277–1288) have...
Kirsch et al. (2008, Initial severity and antidepressant benefits: a meta-analysis of data submitted...
Aforementioned study analysis included published and previously unpublished data submitted to the FD...
BACKGROUND: It is widely believed that in randomized controlled trials of antidepressants the differ...
BACKGROUND: It is widely believed that in randomized controlled trials of antidepressants the differ...
Following the publication of a recent meta-analysis by Cipriani et al., various opinion leaders and ...
The issue of unblinded outcome-assessors and patients has repeatedly been stressed as a flaw in alle...
Item does not contain fulltextImprovements in placebo groups of antidepressant trials account for a ...
It had long been believed that placebo response rates in antidepressant trials have been increasing ...
drugs really any better than placebo? A RECENT study claims anti-depressants are only slightly more ...
The placebo response plays a major role in psychiatry, particularly in depression. A new network met...
The calculation of antidepressant-placebo difference (50% - 30% = 20%) in drug trials is based on th...
The placebo response plays a major role in psychiatry, particularly in depression. A new network met...
International audienceBACKGROUND: Antidepressants are often considered to be mere placebos despite t...
Introduction: During the last decade, a number of meta-analyses questioned the clinically relevant e...
In a recent paper, Horder and colleagues (Horder et al., 2010, J Psychopharmacol 25: 1277–1288) have...
Kirsch et al. (2008, Initial severity and antidepressant benefits: a meta-analysis of data submitted...
Aforementioned study analysis included published and previously unpublished data submitted to the FD...
BACKGROUND: It is widely believed that in randomized controlled trials of antidepressants the differ...
BACKGROUND: It is widely believed that in randomized controlled trials of antidepressants the differ...
Following the publication of a recent meta-analysis by Cipriani et al., various opinion leaders and ...
The issue of unblinded outcome-assessors and patients has repeatedly been stressed as a flaw in alle...
Item does not contain fulltextImprovements in placebo groups of antidepressant trials account for a ...
It had long been believed that placebo response rates in antidepressant trials have been increasing ...
drugs really any better than placebo? A RECENT study claims anti-depressants are only slightly more ...
The placebo response plays a major role in psychiatry, particularly in depression. A new network met...
The calculation of antidepressant-placebo difference (50% - 30% = 20%) in drug trials is based on th...
The placebo response plays a major role in psychiatry, particularly in depression. A new network met...
International audienceBACKGROUND: Antidepressants are often considered to be mere placebos despite t...
Introduction: During the last decade, a number of meta-analyses questioned the clinically relevant e...